Chief Executive Officer Monash University, Australian Stem Cell Centre, Ground Floor, Building 75 (STRIP), Wellington Road, Clayton, VIC 3800, Australia.
Expert Opin Drug Discov. 2008 Mar;3(3):285-8. doi: 10.1517/17460441.3.3.285.
Australia's excellence in medical research, the transparent regulatory regime and its track record in clinical trials are driving a maturing of the country's biomedicine-dominated biotech industry. At the same time, Australia is cementing its position as an international leader in stem cell research. In terms of preclinical drug leads, Australian institutes and universities continue to generate a stream of discoveries with commercial potential. Recent examples include the Gardasil cervical cancer vaccine, now licensed for sale in 80 countries; and the Nobel Prize-winning discovery of the bacteria that causes stomach ulcers. In stem cell science, Australia's place as a world leader can be attributed to its culture of innovation and discovery, clear legislative framework and long history in both adult and embryonic stem cell research.
澳大利亚在医学研究方面的卓越表现、透明的监管制度以及在临床试验方面的记录，推动了该国以生物医学为主导的生物技术产业的成熟。与此同时，澳大利亚也巩固了其在干细胞研究方面的国际领先地位。在临床前药物先导物方面，澳大利亚的研究机构和大学继续不断有具有商业潜力的发现。最近的例子包括 Gardasil 宫颈癌疫苗，现已在 80 个国家获得销售许可；以及发现导致胃溃疡的细菌的诺贝尔奖。在干细胞科学领域，澳大利亚之所以能成为世界领先者，可归因于其创新和发现的文化、明确的立法框架以及在成人和胚胎干细胞研究方面的悠久历史。
